KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Exchange Rate Effect (2016 - 2025)

Pfizer (PFE) has disclosed Exchange Rate Effect for 17 consecutive years, with $5.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Exchange Rate Effect rose 117.24% to $5.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $41.0 million, a 162.12% increase, with the full-year FY2025 number at $41.0 million, up 162.12% from a year prior.
  • Exchange Rate Effect was $5.0 million for Q4 2025 at Pfizer, up from $2.0 million in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $41.0 million in Q2 2025 to a low of -$139.0 million in Q4 2022.
  • A 5-year average of -$17.5 million and a median of -$5.0 million in 2023 define the central range for Exchange Rate Effect.
  • Peak YoY movement for Exchange Rate Effect: plummeted 2800.0% in 2024, then soared 327.78% in 2025.
  • Pfizer's Exchange Rate Effect stood at -$32.0 million in 2021, then crashed by 334.38% to -$139.0 million in 2022, then soared by 99.28% to -$1.0 million in 2023, then tumbled by 2800.0% to -$29.0 million in 2024, then surged by 117.24% to $5.0 million in 2025.
  • Per Business Quant, the three most recent readings for PFE's Exchange Rate Effect are $5.0 million (Q4 2025), $2.0 million (Q3 2025), and $41.0 million (Q2 2025).